The intravenous therapy and vein access devices market has seen considerable growth due to a variety of factors.
• The market for intravenous therapy and vein access devices has seen a robust growth in the past few years. The market is expected to expand from $30.65 billion in 2024 to $33.15 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%.
Factors contributing to the growth during the historic period include the expansion of hospital facilities, increase in intensive care units (ICUs), advancements in medical R&D, and a growing elderly population.
The intravenous therapy and vein access devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of intravenous therapy and vein access devices is predicted to experience significant expansion in the forthcoming years. The expected value of the market is projected to reach $44.69 billion by the year 2029, following a compound annual growth rate (CAGR) of 7.8%.
Factors contributing to this growth during the predicted timeline are the surge in the number of surgical procedures, development of eco-friendly materials, improved infection prevention measures, escalating expenditure on healthcare, and an increase in cases of chronic diseases. The predicted period will likely see trends like the development of minimally invasive techniques, progress in catheter technology, the introduction of intelligent intravenous devices, growth in ultrasound-guided techniques, and new devices emerging in the home healthcare market.
The surge in surgical operations is anticipated to boost the intravenous therapy and vein access devices market's expansion. The increasing need for optional surgeries like cosmetic procedures, plastic surgery, rhinoplasty, and other non-essential surgeries is enhancing the market. Intravenous therapy and vein access devices play a crucial role in surgical operations by providing medicine, anesthesia, liquids, and nutrients. They help maintain patient equilibrium and enable quick intervention when required. For example, the Australian Institute of Health and Welfare, a governmental agency in Australia, reported an 18% rise in patient admissions for surgery from public hospital elective surgery waiting lists in the 2022-23 period, totaling 735,500 compared to the prior year, 2021-22. Hence, the surge in surgical procedures is promoting the expansion of the intravenous therapy and vein access devices market.
The intravenous therapy and vein access devicesmarket covered in this report is segmented –
1) By Type: Intravenous (IV) Therapy And Vein Access Implantable Ports, Intravenous (IV) Therapy And Vein Access Intravenous Catheters, Hypodermic Intravenous (IV) Therapy And Vein Access Needles, Intravenous (IV) Therapy And Vein Access Infusion Pumps, Other Types
2) By Application: Volume Expanders, Medication Administration, Blood-Based Products, Nutrition And Buffer Solutions
3) By End Use: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Intravenous (IV) Therapy and Vein Access Implantable Ports: Single-Lumen Implantable Ports, Double-Lumen Implantable Ports, Triple-Lumen Implantable Ports
2) By Intravenous (IV) Therapy and Vein Access Intravenous Catheters: Peripheral IV Catheters, Central Venous Catheters (CVC), Peripherally Inserted Central Catheters (PICC), Tunneled Catheters
3) By Hypodermic Intravenous (IV) Therapy and Vein Access Needles: Standard Hypodermic Needles, Butterfly Needles, Safety Hypodermic Needles
4) By Intravenous (IV) Therapy and Vein Access Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps, Ambulatory Infusion Pumps
5) By Other Types: IV Administration Sets, IV Fluid Bags and Tubing, Needleless Connectors, IV Drip Chambers
Leading corporations in the intravenous therapy and vein access devices market are innovating short peripheral intravenous catheters to improve patient comfort, decrease complications related to insertion, and augment the effectiveness of administering fluids and medication. Short peripheral intravenous catheters are an efficient resource for directly delivering fluids, medication, and essential nutrients into the bloodstream, thereby reducing patient discomfort, lowering infection risks, and facilitating easy and dependable venous access for various medical procedures. For instance, B. Braun, a medical device company based in Germany, introduced the Introcan Safety 2 IV Catheter in October 2023, a short peripheral intravenous catheter with an automatic needlestick prevention mechanism and a Multi-Access blood control septum. The new advanced catheter is crafted to improve safety for medical personnel by offering automatic needlestick protection and a blood control attribute that reduces the exposure to bloodborne pathogens each time the hub is used.
Major companies operating in the intravenous therapy and vein access devices market are:
• Cardinal Health Inc.
• Johnson & Johnson Services Inc.
• 3M Company
• Medtronic plc
• Becton
• Dickinson and Company
• Baxter International Inc.
• B. Braun Holding GmbH & Co. KG
• Fresenius Kabi AG
• Terumo Corporation
• Mindray Medical International Limited
• Moog Inc.
• West Pharmaceutical Services Inc.
• ICU Medical Inc.
• Insulet Corporation
• Merit Medical Systems Inc.
• Avanos Medical Inc.
• Vygon SAS
• NxStage Medical Inc.
• AngioDynamics Inc.
• Elcam Medical Inc.
• Zyno Medical LLC
• Sippex
North America was the largest region in the intravenous therapy and vein access devices market in 2024. The regions covered in the intravenous therapy and vein access devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.